BANK VONTOBEL/PUT/STRYKER CORP./280/0.1/20.09.24 Stock

Warrant

DE000VM7NTK5

Market Closed - Deutsche Boerse AG 13:41:48 2024-07-01 EDT
0.085 EUR +21.43% Intraday chart for BANK VONTOBEL/PUT/STRYKER CORP./280/0.1/20.09.24
Current month+21.43%
1 month-30.89%
Date Price Change
24-07-01 0.085 +21.43%
24-06-28 0.07 0.00%
24-06-27 0.07 -1.41%
24-06-26 0.071 -5.33%
24-06-25 0.075 0.00%

Delayed Quote Deutsche Boerse AG

Last update July 01, 2024 at 01:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM7NTK
ISINDE000VM7NTK5
Date issued 2023-12-29
Strike 280 $
Maturity 2024-09-20 (81 Days)
Parity 10 : 1
Emission price 1.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.48
Lowest since issue 0.055
Delta-0.05x
Omega 17.78
Premium17.1x
Gearing326.35x
Moneyness 0.8321
Difference Strike -56.5 $
Difference Strike %-20.18%
Spread 0.022
Spread %20.56%
Intrinsic value 0.000000

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
336.5 USD
Average target price
372.9 USD
Spread / Average Target
+10.83%
Consensus